A 1974 graduate of the University of Adelaide, South Australia, Trevor Marshall was additionally awarded a Masters degree in 1978. In 1985 he graduated Ph.D. from the University of Western Australia, with the thesis topic: ‘Insulin metabolism in Diabetes.’ During the ‘1970s he had taught Engineering at the Institute of Technology in Lae, Papua New Guinea, and at Curtin University in Western Australia. He transitioned to Bioengineering in 1978, teaching at the University of Western Australia. In 1981 he was a visiting scientist at the Department of Surgery, Hospital for Sick Children, Toronto. He moved to California in 1982. He is Director of the Autoimmunity Research Foundation in Thousand Oaks, California and an adjunct professor in the Faculty of Health Sciences at Murdoch University, in Western Australia. He is currently best known for his discoveries in Translational Metagenomics and Autoimmune Disease. His treatment for chronic inflammatory diseases has became known as the Marshall Protocol (MP). Collaborative research in the 1980’s led to successful therapies for cryptorchidism, male and female infertility, and diabetes. He has won US FDA designations for minocycline and clindamycin in the treatment of sarcoidosis, and is currently steering the new drug product “Pure Olmesartan” through FDA review. Trevor has keynoted and chaired sessions at international congresses on Autoimmunity, Genomics, and Neurology.